Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.150
-0.060 (-4.96%)
At close: Dec 5, 2025, 4:00 PM EST
1.170
+0.020 (1.74%)
After-hours: Dec 5, 2025, 7:56 PM EST

Company Description

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works.

The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates.

It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands.

The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015.

Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Canopy Growth Corporation
Canopy Growth logo
Country Canada
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 960
CEO Luc Mongeau

Contact Details

Address:
1 Hershey Drive
Smiths Falls, ON K7A 0A8
Canada
Phone 855 558 9333
Website canopygrowth.com

Stock Details

Ticker Symbol CGC
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency CAD
CIK Code 0001737927
CUSIP Number 138035100
ISIN Number CA1380357048
SIC Code 2833

Key Executives

Name Position
Luc Mongeau Chief Executive Officer and Director
Dr. Christelle Gedeon L.L.B., Ph.D. Chief Legal Officer and Corporate Secretary
Thomas Carlton Stewart CPA Chief Accounting Officer and Chief Financial Officer
Bryan Murphy Senior Vice President of Operations
Jenny Brewer Chief Human Resources Officer
Jason Green Head of Agriculture - Hemp Division
Jurgen Bickel MD and Co-Founder of STORZ and BICKEL GmbH
Andrew Bevan Senior Vice President of Medical Sales
Miles Worne Managing Director of European Markets
Tyler Burns Director of Investor Relations

Latest SEC Filings

Date Type Title
Nov 7, 2025 8-K Current Report
Nov 7, 2025 10-Q Quarterly Report
Oct 14, 2025 8-K Current Report
Sep 26, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Sep 24, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Sep 19, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Sep 17, 2025 8-K Current Report
Sep 3, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Aug 29, 2025 8-K Current Report
Aug 29, 2025 424B5 Filing